AG
KRRO icon

Artal Group’s Korro Bio KRRO Stock Holding History

Artal Group’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-413,072
Closed -$14M – 51
2024
Q2 		$14M Sell
413,072
-6,154
-1% -$340K 0.36% 32
2024
Q1 		$37.7M Buy
419,226
+621
+0.1% +$33.9K 0.96% 16
2023
Q4 		$20.1M Buy
+418,605
New +$13.8M 0.67% 22

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Artal Group's KRRO Position: Q3 2024 in Review

Artal Group sold out of Korro Bio (KRRO) in Q3 2024, closing a stake of 413,072 shares — an estimated $14M sold.

Artal Group first reported a position in KRRO in Q4 2023 and held it in 3 quarters. The position peaked at $37.7M in Q1 2024. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2024.

  • Artal Group reported no remaining Korro Bio position as of Q3 2024 after selling out during the quarter.
  • Artal Group sold 413,072 Korro Bio shares in Q3 2024, an estimated $14M.
  • Artal Group first reported a position in Korro Bio in Q4 2023 and held it in 3 quarters.
  • Artal Group's Korro Bio position peaked at $37.7M in Q1 2024.
  • 71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.